W
Winnie Yeo
Researcher at The Chinese University of Hong Kong
Publications - 291
Citations - 19511
Winnie Yeo is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 60, co-authored 282 publications receiving 16440 citations. Previous affiliations of Winnie Yeo include University of Hong Kong.
Papers
More filters
Journal ArticleDOI
Supportive care needs in Hong Kong Chinese women confronting advanced breast cancer
Angel Au,Wendy W. T. Lam,Janice Tsang,Tsz Kok Yau,I Soong,Winnie Yeo,J Suen,Wing M. Ho,Ka Yan Wong,Ava Kwong,Dacita Suen,Wing Kin Sze,Alice Ng,Afaf Girgis,Richard Fielding +14 more
TL;DR: The type and extent of unmet supportive care needs in Hong Kong Chinese women with advanced breast cancer are investigated in this cross‐sectional study.
Journal ArticleDOI
The evolution of psychological distress trajectories in women diagnosed with advanced breast cancer: A longitudinal study
Wendy W. T. Lam,I Soong,TK Yau,K. Y. Wong,Jwh Tsang,Winnie Yeo,J Suen,Wing M. Ho,Wing Kin Sze,A Ng,Ava Kwong,Dtk Suen,Richard Fielding +12 more
TL;DR: T trajectories of distress and their determinants in Chinese women with ABC are described in this study.
Journal ArticleDOI
Knowledge, perceptions, and attitudes of Hong Kong Chinese women on screening mammography and early breast cancer management.
TL;DR: Interventions to improve the accuracy of information and to encourage preventive health care behaviors will have a positive impact on establishing cancer screening programs and providing quality cancer care in the future.
Journal ArticleDOI
Targeted therapy of hepatocellular carcinoma: Present and future
Stephen L. Chan,Winnie Yeo +1 more
TL;DR: The current status of clinical development of targeted therapy in HCC is summarized, with focus on novel agents targeting angiogenesis, signal transduction and epigenetic dysregulation of tumors.
Journal Article
Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
TL;DR: HCC has the highest incidence of promoter methylation of RASSF1A among all malignancies yet reported suggesting that hypermethylation of the CpG island promoter of Rassingf1A may play an important pathological role in this tumor.